Correction: Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors
Metrics: PDF 821 views | ?
Present: The currently listed corresponding author, John C. Herr, is deceased. Oncotarget wishes to express our condolences to his family and colleagues.
Corrected: The new correspondence author information is as follows.
Original article: Oncotarget. 2015; 6(30):30194-211. DOI: 10.18632/oncotarget.4734
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.